{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T06:22:50Z","timestamp":1782022970875,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vph.2019.106635","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T20:29:17Z","timestamp":1576614557000},"page":"106635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Aspirin antiplatelet effects are associated with body weight"],"prefix":"10.1016","volume":"125-126","author":[{"given":"Philipp","family":"Mourikis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Zako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Dannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Helten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Levkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2019.106635_bb0005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.trsl.2014.03.010","article-title":"The relationship between obesity and coronary artery disease","volume":"164","author":"Jahangir","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.vph.2019.106635_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-016-0575-4","article-title":"Obesity and cardiovascular disease: a risk factor or a risk marker?","volume":"18","author":"Mandviwala","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2019.106635_bb0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2019.106635_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2015.12.021","article-title":"Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention","volume":"138","author":"Komosa","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2019.106635_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2019.106635_bb0030","article-title":"Association between high platelet reactivity following dual antiplatelet therapy and ischemic events in Japanese patients with coronary artery disease undergoing stent implantation","author":"Nishikawa","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2019.106635_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vph.2016.06.003","article-title":"Dipyrone comedication in aspirin treated stroke patients impairs outcome","volume":"87","author":"Dannenberg","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2019.106635_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jth.13211","article-title":"Antiplatelet effects of aspirin in chronic kidney disease patients","volume":"14","author":"Polzin","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106635_bb0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2004.12.038","article-title":"Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction","volume":"95","author":"Schwartz","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2019.106635_bb0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40262-017-0611-8","article-title":"Obesity and altered aspirin pharmacology","volume":"57","author":"Norgard","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.vph.2019.106635_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/376721","article-title":"Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms","volume":"2012","author":"Rocca","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.vph.2019.106635_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/erc.12.144","article-title":"Identifying determinants of variability to tailor aspirin therapy","volume":"11","author":"Rocca","year":"2013","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2019.106635_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2019.106635_bb0070","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"Sibbing","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.vph.2019.106635_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.vph.2019.106635_bb0080","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/j.1538-7836.2010.03997.x","article-title":"The role of weight and enteric coating on aspirin response in cardiovascular patients","volume":"8","author":"Peace","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106635_bb0085","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106635_bb0090","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2019.106635_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1160\/TH15-02-0179","article-title":"Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing","volume":"114","author":"Freynhofer","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106635_bb0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2257.1990.tb00035.x","article-title":"Interrelationship between platelet count, red cell count, white cell count and weight in men","volume":"12","author":"Siebers","year":"1990","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.vph.2019.106635_bb0105","first-page":"1300","article-title":"How obesity affects the neutrophil\/lymphocyte and platelet\/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study","volume":"20","author":"Furuncuoglu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.vph.2019.106635_bb0110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2147\/CIA.S138592","article-title":"Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease","volume":"12","author":"Zhang","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.vph.2019.106635_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trsl.2018.05.009","article-title":"Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet count","volume":"200","author":"Gremmel","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.vph.2019.106635_bb0120","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Davi","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2019.106635_bb0125","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2008.03184.x","article-title":"Aspirin \u2018resistance\u2019: role of pre-existent platelet reactivity and correlation between tests","volume":"6","author":"Frelinger","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106635_bb0130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvx086","article-title":"New insights into the role of adipose tissue in thrombosis","volume":"113","author":"Vilahur","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2019.106635_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/j.1550-8528.1995.tb00119.x","article-title":"Fibrinogen in obesity before and after weight reduction","volume":"3","author":"Ditschuneit","year":"1995","journal-title":"Obes. Res."},{"key":"10.1016\/j.vph.2019.106635_bb0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12185-010-0652-3","article-title":"Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes","volume":"92","author":"Addad","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.vph.2019.106635_bb0145","article-title":"Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis","volume":"16","author":"Bundhun","year":"2016","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119303374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119303374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:18:41Z","timestamp":1761527921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189119303374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"alternative-id":["S1537189119303374"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2019.106635","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin antiplatelet effects are associated with body weight","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2019.106635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106635"}}